Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis

Several studies have shown that liver resection (LR) confers better survival outcomes in intermediate- and advanced-stage hepatocellular carcinoma (HCC) patients. However, the postoperative recurrence rate is high, and little is known about the survival benefits of LR for recurrent HCC patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsueh, Kuan-Chun, Lee, Cheng-Chun, Huang, Pi-Teh, Liang, Chih-Yu, Yang, Shun-Fa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047492/
https://www.ncbi.nlm.nih.gov/pubmed/36975456
http://dx.doi.org/10.3390/curroncol30030243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047492/
https://www.ncbi.nlm.nih.gov/pubmed/36975456
http://dx.doi.org/10.3390/curroncol30030243

Ejemplares similares